Toxoplasma gondii infection in a group of schizophrenic colombian patients

Jaime Valero; Juan F. Cano; Rodrigo Nel Cordoba Rojas; Ligia Alejandra De la Torre Cifuentes; Laura Ramirez

Toxoplasma gondii infection in a group of schizophrenic colombian patients

Título traducido de la contribución: Infección por Toxoplasma gondii en un grupo de pacientes colombianos con esquizofrenia

Jaime Valero, Juan F. Cano, Rodrigo Nel Cordoba Rojas, Ligia Alejandra De la Torre Cifuentes, Laura Ramirez

Producción científica: Contribución a una conferencia › Póster › revisión exhaustiva

23 Descargas (Pure)

Resumen

Este estudio de casos y controles pretende determinar si existe una mayor prevalencia de anticuerpos IgG contra Toxoplasma gondii en pacientes colombianos con esquizofrenia en comparación con ( versus ) un grupo de personas sin este diagnóstico o (controles sanos). Estudios realizados en varios países han mostrado una fuerte asociación entre anticuerpos contra toxoplasma y esquizofrenia, lo que ha planteado varias hipótesis y algunas nuevas visiones sobre la presencia del parásito en la fisiopatología de esta enfermedad. Nuestro objetivo secundario es analizar si existe relación entre las cepas de toxoplasma existentes en nuestro país y la presencia de la enfermedad. Se completará un observacional descriptivo en relación con los factores de riesgo genéticos y sociales.

Título traducido de la contribución	Infección por Toxoplasma gondii en un grupo de pacientes colombianos con esquizofrenia
Idioma original	Inglés estadounidense
Páginas	613-614
Número de páginas	2
Estado	Publicada - may. 21 2019
Evento	American Psychiatric Association (APA) 172nd Annual Meeting - Moscone Center, San Francisco, Estados Unidos Duración: may. 18 2019 → may. 22 2019 Número de conferencia: P8-177

Conferencia

Conferencia	American Psychiatric Association (APA) 172nd Annual Meeting
Título abreviado	APA
País/Territorio	Estados Unidos
Ciudad	San Francisco
Período	5/18/19 → 5/22/19

Áreas temáticas de ASJC Scopus

Medicina General

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

Poster-Proceedings APA 2019Versión de la editorial, 5,57 MBLicencia: Sin especificar

Citar esto

@conference{0ceb4a5d97a3472499459f77a4f4947b,

title = "Toxoplasma gondii infection in a group of schizophrenic colombian patients",

abstract = "This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors. ",

author = "Jaime Valero and Cano, {Juan F.} and {Cordoba Rojas}, {Rodrigo Nel} and {De la Torre Cifuentes}, {Ligia Alejandra} and Laura Ramirez",

note = "Yolken RH, Dickerson FB, & Fuller-Torrey E. Toxoplasma and schizophrenia. Parasite Inmunology 2009; 31(1): 706-715; American Psychiatric Association (APA) 172nd Annual Meeting ; Conference date: 18-05-2019 Through 22-05-2019",

year = "2019",

month = may,

day = "21",

language = "English (US)",

pages = "613--614",

}

Toxoplasma gondii infection in a group of schizophrenic colombian patients. / Valero, Jaime; Cano, Juan F.; Cordoba Rojas, Rodrigo Nel et al.
2019. 613-614 Sesión de cárteles presentada en American Psychiatric Association (APA) 172nd Annual Meeting, San Francisco, California, Estados Unidos.

Producción científica: Contribución a una conferencia › Póster › revisión exhaustiva

TY - CONF

T1 - Toxoplasma gondii infection in a group of schizophrenic colombian patients

AU - Valero, Jaime

AU - Cano, Juan F.

AU - Cordoba Rojas, Rodrigo Nel

AU - De la Torre Cifuentes, Ligia Alejandra

AU - Ramirez, Laura

N1 - Conference code: P8-177

PY - 2019/5/21

Y1 - 2019/5/21

N2 - This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors.

AB - This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors.

M3 - Poster

SP - 613

EP - 614

T2 - American Psychiatric Association (APA) 172nd Annual Meeting

Y2 - 18 May 2019 through 22 May 2019

ER -